- Novo Nordisk shares rise after Wegovy recommended by Britain’s drug price regulator CNBC
- Weight-loss jabs will be offered on NHS for people at risk of further heart attacks BBC
- British drug-cost watchdog recommends use of Novo’s Wegovy to lower heart risks Reuters
- NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes The Guardian
- Novo’s Wegovy to Reach 1.2 Million More Patients in England Bloomberg.com
First Appeared on
Source link
